Latest News and Press Releases
Want to stay updated on the latest news?
-
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
-
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
-
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...